Press Releases

IR Mobile SiteEmail pagePDF viewPrint viewRSS FeedsEmail AlertSocial Media Sharing


Year:
Notify me when new press releases are posted to this site.
Press Releases
7/28/2014Cubist to Present at August Investor Conference
7/22/2014Cubist Reports Second Quarter 2014 Financial Results
7/15/2014Cubist to Announce Second Quarter 2014 Financial Results on Tuesday, July 22, 2014
6/20/2014Cubist’s SIVEXTRO™ (tedizolid phosphate) Approved in U.S. to Treat Serious Skin Infections—Including Those Caused by MRSA
6/19/2014Cubist Announces Acceptance of Ceftolozane/Tazobactam New Drug Application with Priority Review
6/06/2014Cubist Announces Publication of Pivotal Data from SIVEXTRO™ (tedizolid phosphate) ESTABLISH-2 Clinical Trial in The Lancet Infectious Diseases
6/02/2014Cubist to Present at June Investor Conferences
5/09/2014Cubist Presents Detailed Results from Positive Phase 3 Trials of Ceftolozane/Tazobactam at 2014 European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
4/30/2014Cubist to Present New Antibiotics Pipeline Data at 2014 European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
4/23/2014Cubist and Cambridge Science Festival Announce 2014 Germ Challenge Science Contest Winners
4/22/2014Cubist Pharmaceuticals Reports First Quarter 2014 Financial Results
4/21/2014Cubist Announces Submission of New Drug Application for Investigational Antibiotic Ceftolozane/tazobactam
More Press Releases...
 
 Source: SNL Financial LC 
Optimer Press Releases
8/1/2013 Optimer Reports Second Quarter 2013 Financial Results
5/9/2013 Optimer Reports First Quarter 2013 Financial Results
4/26/2013 DIFICID® (fidaxomicin) Tablets Approved in Australia
2/28/2013 Optimer Reports Fourth Quarter and Fiscal Year 2012 Financial Results
More Optimer Press Releases...



Trius Press Releases
6/12/2013 Trius Therapeutics Announces Publication of Antibiotic Safety Study in Antimicrobial Agents and Chemotherapy
5/13/2013 Trius Announces Notice of Allowance of U.S. Patent Application Related to Tedizolid Phosphate Combination With Daptomycin
4/29/2013 Trius Therapeutics Presents Clinical Data on Experimental Antibiotic Tedizolid at ECCMID Meeting
4/23/2013 Trius Therapeutics to Present Experimental Antibiotic Study Results at ECCMID Meeting
More Trius Press Releases...

Copyright 2014, © SNL Financial LC  Terms of Use